Getting there? Salvage therapy for refractory Langerhans cell histiocytosis in children

European Journal of Cancer

Volumn 41, Issue 17, 2005, Pages 2592-2594

  Weitzman, Sheila ^a   Pritchard, Jon ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; CORTICOSTEROID; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; METHOTREXATE; VINBLASTINE; VINCRISTINE;

ACUTE MYELOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANEMIA; AUSTRALIA; BLOOD BRAIN BARRIER; BONE MARROW SUPPRESSION; CAUSE OF DEATH; CHILDHOOD DISEASE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; CYTOTOXICITY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG MEGADOSE; EDITORIAL; FOLLOW UP; GERMANY; HEMATOPOIETIC SYSTEM; HIGH RISK PATIENT; HISTIOCYTOSIS X; HUMAN; IMMUNOREGULATION; INFECTIOUS COMPLICATION; LIVER; LUNG; MONOTHERAPY; PANCYTOPENIA; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; QUALITY CONTROL; RISK ASSESSMENT; SALVAGE THERAPY; SPLEEN; THROMBOCYTOPENIA;

CHILD; CHRONIC DISEASE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; SALVAGE THERAPY;

EID: 27744560454     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.07.008     Document Type: Editorial

References (24)

1. M. Minkov, N. Grois, and A. Heitger Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator Med Pediatr Oncol 39 2002 581 585
2. H. Gadner, N. Grois, and M. Arico A randomized trial of treatment for multisystem Langerhans' cell histiocytosis J Pediatr 138 2001 728 734
3. The French LCH Study Group. A multicentre retrospective survey of LCH: 348 cases observed between 1983 and 1993. Arch Dis Child 1996, 75, 17-24.
4. S. Ladisch, H. Gadner, and M. Aricó A randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis Med Pediatr Oncol 23 1994 107 110
5. A. Ceci, M. de Terlizzi, and R. Colella Etoposide in recurrent childhood Langerhans' cell histiocytosis: an Italian cooperative study Cancer 62 1988 2528 2531
6. H. Mahmoud, W. Wang, and S. Murphy Cyclosporine therapy for advanced Langerhans cell histiocytosis Blood 77 1991 721 725
7. R.M. Egeler, J. de Kraker, and P.A. Voûte Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution Med Pediatr Oncol 21 1993 265 270
8. R.J. Arceci, M.K. Brenner, and J. Pritchard Controversies and new approaches to treatment of Langerhans cell histiocytosis Haematol Oncol Clin N Am 12 1998 339 357
9. A. Saven, K. Foon, and L. Piro 2-Chlorodeoxyadenosine induced complete remissions in Langerhans cell histiocytosis Ann Intern Med 21 1994 430 432
10. A. Saven, and C. Burian Cladribine activity in adult Langerhans cell histiocytosis Blood 93 1999 4125 4130
11. K.C. Stine, R.L. Saylors, and L.L. Willimas 2-Chorodeoxyadenosine(2-CdA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients Med Pediatr Oncol 29 1997 288 292
12. C. Rodriguez-Galindo, P. Kelly, and M. Jeng Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine Am J Hematol 69 2002 179 184
13. M. Minkov, N. Grois, and V. Broadbent Cyclosporine A therapy for multisystem Langerhans cell histiocytosis Med Pediatr Oncol 33 1999 482 485
14. S. Weitzman, R. Arceci, and J. Braier 2-Chlorodeoxyadenosine (2-CDA) as salvage therapy for Langerhans cell histiocytosis (LCH). Results of LCH-S-98 Pediatr Blood Cancer 45 2005 95
15. S.W. Choi, B.S. Bangaru, and C.D. Wu Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine J Pediatr Hematol Oncol 25 2003 503 506
16. V. Gandhi, E. Estey, and M.J. Keating Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic and molecular interactions Blood 87 1996 256 264
17. K.R. Crews, V. Gandhi, and D.K. Srivastava Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia J Clin Oncol 20 2002 4217 4224
18. J. Liliemark, and G. Juliusson On the pharmacokinetics of 2-chloro-2-deoxyadenosine (CdA) in cerebrospinal fluid(CSF) Blood 80 1992
19. J. Watts, and B. Files Langerhans cell histiocytosis: central nervous system involvement treated successfully with 2-chlorodeoxyadenosine Pediatr Hematol Oncol 18 2001 199 204
20. F. Ottaviano, and J.L. Finlay Diabetes Insipidus and Langerhans cell histiocytosis: a case report of reversibility with 2-chlorodeoxyadenosine J Pediatr Hematol/Oncol 25 2003 575 577
21. K.M. Kelly, and J. Pritchard Monoclonal antibody therapy in Langerhans cell histiocytosis-feasible and reasonable? Br J Cancer 23 Suppl. 1994 S54 S55
22. C. Perreault, M. Pelletier, and D. Landry Study of Langerhans cells after allogeneic bone marrow transplantation Blood 63 1984 807 811
23. S. Weitzman, K. McClain, and R. Arceci Treatment of relapsed and/or refractory Langerhans cell histiocytosis S. Weitzman R.M. Egeler Histiocytic Disorders of Children and Adults 2005 Cambridge University Press Cambridge 254 271
24. J. Donadieu, F. Piguet, and M. Bernard A new clinical score for disease activity in Langerhans cell histiocytosis Pediatr Blood Cancer 43 2004 770 776